Award

Delivery Order #SPE2D326F6616

Delivery Order for Ketorolac Vials to DoD from Fresenius Kabi

Buyer

Defense Logistics Agency

Award Amount

$426.28

Ceiling

$426.28

Awarded

February 26, 2026

Period of Performance

Feb 26, 2026 – Feb 27, 2026

Identifier

SPE2D326F6616

NAICS

325411

This award represents a delivery order contract under an existing indefinite delivery/indefinite quantity (ID/IQ) contract awarded to Fresenius Kabi, LLC, a company specializing in pharmaceutical manufacturing and distribution. The contract involves the procurement of Ketorolac 30 MG/ML vials, a critical pharmaceutical product used for pain management. This delivery order supports the Department of Defense's continued need for essential medical supplies to maintain operational readiness and effective healthcare for military personnel. The scope includes the delivery of specified pharmaceutical vials within a short performance period. The order was placed as part of a competitive and ongoing procurement strategy under a broader, long-term contract awarded through competitive means to ensure reliable supply. The contract's timeline covers a brief, multi-day delivery window, aligning with the need for timely replenishment of medical stock. This delivery order is linked to a significant parent indefinite delivery contract that secures critical medical supplies for the U.S. Armed Forces, highlighting its role within a large-scale, multi-year supply framework.

Description

4571025535!KETOROLAC 30 MG/ML VIALML

View original record